S
Surajit Das
Researcher at Agency for Science, Technology and Research
Publications - 38
Citations - 2552
Surajit Das is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Drug carrier & Drug delivery. The author has an hindex of 19, co-authored 38 publications receiving 2156 citations. Previous affiliations of Surajit Das include Procter & Gamble & National University of Singapore.
Papers
More filters
Journal ArticleDOI
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Surajit Das,Anumita Chaudhury +1 more
TL;DR: In this article, a review of lipid nanoparticles based on solid matrix has been conducted to improve the oral bioavailability of several drugs, especially lipophilic compounds, and the stability of the formulations might increase than other liquid nano-carriers due to the solid matrix.
Journal ArticleDOI
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
TL;DR: NLCs demonstrated faster drug release than SLNs at low drug-loading, whereas there was no significant difference in drug release from SLNs and NLCs at high drug- loading, however, sustained/prolonged drug release was observed from both formulations.
Journal ArticleDOI
Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
TL;DR: The developed solid lipid nanoparticles of a hydrophobic drug, tretinoin, can be used as drug carrier for sustained/prolonged drug release and/or to improve oral absorption/bioavailability.
Journal ArticleDOI
The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol
TL;DR: Aqueous solubility barrier might affect the speed but not the extent of resveratrol absorption, but, dose manipulation did not have a significant impact on the oral bioavailability of res veratrol.
Journal ArticleDOI
Recent Advancement of Chitosan-Based Nanoparticles for Oral Controlled Delivery of Insulin and Other Therapeutic Agents
Anumita Chaudhury,Surajit Das +1 more
TL;DR: The current review focuses on the recent advancements in the field of oral controlled release via chitosan nanoparticles and discusses about its in vitro and in vivo implications.